[Federal Register Volume 75, Number 89 (Monday, May 10, 2010)]
[Notices]
[Pages 25860-25861]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-11058]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-10-10BA]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to [email protected]. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-3806. 
Written

[[Page 25861]]

comments should be received within 30 days of this notice.

Proposed Project

    Development and Testing of an HIV Prevention Intervention Targeting 
Black Bisexually-Active Men--New--National Center for HIV/AIDS, Viral 
Hepatitis, STD, and Tuberculosis Prevention (NCHHSTP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    African Americans continue to be disproportionately affected by 
HIV/AIDS. Results from the National HIV Behavioral Surveillance Project 
showed that during 2001-2004 African-Americans accounted for the 
majority of HIV/AIDS diagnoses in 33 states. Black men who have sex 
with men (MSM) have been identified as the population with the highest 
rates of HIV infection in the U.S. and as a population in need of new 
HIV prevention interventions. Previous research indicates that 20% to 
40% of Black MSM also have female sex partners. Interventions developed 
for gay men may not be relevant or appropriate for men who have sex 
with men and women (MSMW), many of whom do not self-identify as gay and 
who may need different prevention strategies for their male and female 
partners. There are no effective HIV risk reduction interventions for 
African-American MSMW.
    The purpose of the proposed study is to develop and pilot-test 
three novel behavioral interventions to reduce sexual risk for HIV 
infection and transmission among African-American MSMW who do not 
inject drugs. Eligible respondents will be recruited using chain 
referral sampling techniques. Three study sites (Public Health 
Management Corporation (PHMC), Nova Southeastern University (NOVA), and 
California State University (CSU) at Dominguez Hills) will use a 
randomized controlled trial to evaluate the effectiveness of the 
intervention. Depending on the site, respondents will be reimbursed up 
to a total of $305 for their time and effort over the course of the 
study. If these interventions are found to be effective, organizations 
that implement risk-reduction interventions will be able to use the 
curricula to intervene with this population more successfully. 
Ultimately, the beneficiary of this data collection will be African-
American MSMW. There is no cost to respondents other than their time. 
The total estimated annual burden hours are 2,250.

                                       Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
                                                                                                  Average burden
          Type of respondent                    Form name            Number of     Responses per   per response
                                                                    respondents     respondents     (in hours)
----------------------------------------------------------------------------------------------------------------
Prospective Participant...............  Screener................           1,250               1            5/60
Enrolled Participant..................  Locator Form............             750               1           10/60
Enrolled Participant--PHMC............  Baseline Assessment.....             250               1               1
Enrolled Participant--Nova............  Baseline Assessment.....             240               1               1
Enrolled Participant--CSU.............  Baseline Assessment.....             260               1               1
Enrolled Participant--PHMC............  Acceptability/                       250               6           10/60
                                         Feasibility Survey.
Enrolled Participant--Nova............  Acceptability/                       240               1           10/60
                                         Feasibility Survey.
Enrolled Participant--CSU.............  Acceptability/                       260               1           10/60
                                         Feasibility Survey.
Enrolled Participant--PHMC............  Immediate Follow-Up                  225               1           30/60
                                         Assessment.
Enrolled Participant--Nova............  Immediate Follow-Up                  216               1           30/60
                                         Assessment.
Enrolled Participant--CSU.............  Immediate Follow-Up                  234               1           30/60
                                         Assessment.
Enrolled Participant--PHMC............  3 month Follow-Up                    200               1               1
                                         Assessment.
Enrolled Participant--Nova............  3 month Follow-Up                    192               1               1
                                         Assessment.
Enrolled Participant--CSU.............  3 month Follow-Up                    208               1               1
                                         Assessment.
----------------------------------------------------------------------------------------------------------------


    Dated: May 4, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2010-11058 Filed 5-7-10; 8:45 am]
BILLING CODE 4163-18-P